154 episodes

BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more.

Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries.

Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.

BioTalk with Rich Bendis BioHealth Innovation, Inc. (BHI)

    • Business
    • 4.7 • 11 Ratings

BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more.

Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries.

Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.

    Building Baltimore's Future: Kory Bailey and the UpSurge Vision

    Building Baltimore's Future: Kory Bailey and the UpSurge Vision

    Join us in this episode of BioTalk with Rich Bendis as we delve into the Baltimore ecosystem with Kory Bailey, Chief Ecosystem Officer (CEO) of UpSurge Baltimore, a trailblazing organization dedicated to fostering equitable economic growth and innovation.
    Kory Bailey brings over a decade of leadership experience from both early-stage startups and big tech. He has emerged as a thought leader on equitable economic growth and a champion for Baltimore's tech ecosystem. As the CEO of UpSurge Baltimore, Kory is spearheading the vision for Baltimore to become the first Equitech hub globally, pioneering a new model for American innovation.
    In this discussion, Kory unveils UpSurge Baltimore's mission: to cultivate a thriving tech ecosystem for innovators, founders, and talent by fostering culture and connectivity and mobilizing regional and national assets around Baltimore startups.
    From exploring what drew him to Baltimore to discussing the evolution and unique aspects of UpSurge, Kory shares insights into the philanthropic landscape in Baltimore and initiatives like the Equitech Accelerator, Techstars, KHU, and CareFirst. He also delves into the primary challenges facing Baltimore and UpSurge's short-term goals focused on accountability, awareness, investment, and early-stage support.
    Join us as we envision Baltimore's future in the next five years and the pivotal role UpSurge Baltimore plays in shaping it. Tune in now to be part of the conversation driving equitable economic growth and innovation in Baltimore's tech ecosystem.

    • 43 min
    John Sackett - Execuitve Vice President & COO, Adventist Healthcare

    John Sackett - Execuitve Vice President & COO, Adventist Healthcare

    Discover the Future of Healthcare with John Sackett, Executive Vice President & COO of Adventist Healthcare, on BioTalk with Rich Bendis.

    In this episode, John Sackett shares his insights into the changing landscape of healthcare delivery. From his early days as an administrative assistant to his current role, John's journey offers invaluable lessons on leadership and innovation in the healthcare industry.

    Join us as we explore Adventist Healthcare's role in the BioHealth Capital Region (BHCR) and explore the transformative changes in healthcare delivery. Gain valuable insights into the challenges and innovations reshaping healthcare post-COVID and learn how Adventist Healthcare is leading the way in patient-centered care.

    In a candid and inspiring segment, John opens up about his personal journey of managing cystic fibrosis while excelling in his career. Discover the remarkable advancements in the treatment and life expectancy of CF patients, highlighting the power of innovation and resilience in overcoming adversity.

    Don't miss this enlightening episode as we navigate the evolving landscape of BioHealth Innovation and the BHCR Region with John Sackett, a visionary leader shaping the future of healthcare.

    • 42 min
    Empowering Change: Lance Kawaguchi's Journey with the Cure Brain Cancer Foundation

    Empowering Change: Lance Kawaguchi's Journey with the Cure Brain Cancer Foundation

    Join us for an engaging episode of BioTalk as we sit down with Lance Kawaguchi, Chief Executive Officer of the Cure Brain Cancer Foundation. Lance's career trajectory from global finance to non-profit leadership is as inspiring as it is impactful, driven by a personal mission to combat brain cancer following the loss of his mother.
     
    In this episode, we explore Lance's journey from senior investment banker to non-profit leader, propelled by personal loss and a vision for change. We delve into the SouthPoleTrek4Cancer initiative, spearheading a global effort to raise awareness and funds for brain and rare cancer charities, culminating in a historic journey to the South Pole. We recognize Lance's leadership achievements, including ringing the Nasdaq bell twice as a cancer charity CEO, and his success in bringing the GBM AGILE Clinical Trial Platform from the US to Australia, accelerating breakthrough research efforts.
     
    We also discuss Lance's strategic plans for growth and impact in the BioHealth Capital Region, driving forward the Cure Brain Cancer Foundation's mission. Additionally, we introduce the esteemed medical and scientific advisory committee steering the foundation's groundbreaking initiatives.
     
    Join us for an insightful discussion as we uncover Lance Kawaguchi's transformative journey and the innovative strides being made in the fight against brain cancer. Tune in to BioTalk and be inspired!
     

    • 27 min
    Nanochon's Orthopedic Revolution: A New Era in Cartilage Restoration

    Nanochon's Orthopedic Revolution: A New Era in Cartilage Restoration

    Are you prepared to discover a transformative shift in orthopedic innovation? Join us in this episode of BioTalk with Rich Bendis as step into the world of Nanochon with CEO Ben Holmes.
     
    Nanochon is leading the charge in the field of medical technology, reimagining the landscape of joint injury treatment. Their inventive implant not only restores damaged cartilage but also fosters fresh tissue growth. Utilizing cutting-edge 3-D printing technology and groundbreaking material, Nanochon's implant serves as both a resilient orthopedic load-bearing device and a scaffold for tissue regeneration. This advancement is poised to redefine patient recoveries, trim healthcare costs, and establish new benchmarks in cartilage rehabilitation.
     
    In this episode, we learn about Nanochon's beginnings, the uniqueness of their technology, the individuals constituting their team, their funding strategies, and the challenges they've overcome.
     
    Don't miss this episode as we venture into the frontier of advanced medical solutions with Nanochon. Tune in now and be part of the conversation reshaping the future of joint health.
     

    • 44 min
    Advancing Hope: Solaxa’s Quest to Treat Cerebellar Ataxias

    Advancing Hope: Solaxa’s Quest to Treat Cerebellar Ataxias

    In this episode of BioTalk with Rich Bendis, we’re joined by three guests from Solaxa: CEO & Founder Christian Walker, Chief Operating Officer Luis T. Gutierrez, Jr., and Chief Commercial Officer Jennifer Butler. Solaxa is a pioneering biotech company with a mission to revolutionize the treatment of cerebellar ataxias and acute nerve injuries caused by trauma and chemotherapy.
     
    Discover the compelling story behind Solaxa’s choice to establish its roots in Montgomery County and how the BioHealth Capital Region has played a crucial role in its growth. Learn how Solaxa’s team was assembled, including the inspiring success stories of Luis and Jennifer, both part of the BioHealth Innovation and Montgomery County Maryland’s Executive in Residence program.
     
    Hear how Solaxa is making a difference in the world of neurology with SLX-001, a drug showing immense promise in treating cerebellar ataxias. Dive into their innovative approach, including the development of their treatment for cerebellar ataxias.
     
    Additionally, discover how Solaxa’s pioneering efforts in this field provide hope for healing. Join us for an enlightening discussion on the future of neurology, innovative treatments, and the remarkable journey of Solaxa.
     
    CEO & Founder Christian Walker has focused his last twenty years pursuing the commercialization of nerve injury solutions. Christian’s fundraising experience spans raising money for start-ups, being a start-up venture capitalist, and securing significant non-dilutive financing through grants. At Christian’s prior start-ups, Christian was directly responsible for securing $11M in venture financing.   While at Toucan Capital, he served as Principal of a $140 million venture capital fund focused on early-stage investments in stem cells and regenerative medicine. At Johns Hopkins and Walter Reed, he helped secure $22.5M in non-dilutive grants.
     
    Luis T. Gutierrez, Jr. serves as Chief Operating Officer of Solaxa while also serving as an Executive in Residence with BioHealth Innovation.   In both roles, he leverages his 25+ years of expertise in helping novel medical technologies with scientific and clinical promise transition to becoming successful commercial enterprises.    He previously served in executive roles with Veranex, Theralink Technologies, Aptiv Solutions, and Covance.
     
    Chief Commercial Officer Jennifer Butler has 25 years of broad biotechnology industry experience. Her commercial roles at MedImmune, AstraZeneca, and Innate have equipped her with a deep understanding of commercial execution at large and emerging biopharma. Notably, Jen launched Innate’s first commercial product in a rare oncology population. Jennifer also is also serving as an Executive in Residence with BioHealth Innovation.
     

    • 33 min
    Navigating the AI Wave: Dr. Juergen Klenk Explores AI's Reality in the BioHealth Industry

    Navigating the AI Wave: Dr. Juergen Klenk Explores AI's Reality in the BioHealth Industry

    Have you ever wondered about the true impact of Artificial Intelligence (AI) in the BioHealth industry? In this episode of BioTalk with Rich Bendis, we have the privilege of hosting Dr. Juergen Klenk, a Principal at Deloitte and a Board Member at BioHealth Innovation. Dr. Klenk brings a wealth of expertise and experience with a unique background combining formal scientific training and entrepreneurial ventures.
     
    Join us as we embark on an insightful discussion about the current state of AI in the BioHealth industry, diving deep into the realities and challenges of this cutting-edge technology. Dr. Klenk shares his interest in AI and the reasons behind its increasing prominence in the field. We explore the historical origins of the AI hype cycle and how we've reached the stage we're in today.
     
    Discover tangible examples that illustrate AI's true value, benefits, and impact in BioHealth. Dr. Klenk sheds light on the underlying key technologies that power AI and the associated challenges and risks.
     
    Looking to the future, we examine the outlook for AI in the coming months, years, and even this decade. Will the AI hype continue, or will we witness substantial breakthroughs and transformations? Dr. Klenk offers valuable insights into what organizations can and should do to ride the AI wave effectively.
     
    Don't miss this engaging conversation with Dr. Juergen Klenk as we navigate the exciting world of AI in the BioHealth industry. Tune in now to gain a deeper understanding of AI's reality and its potential to shape the future of healthcare and research.
     

    • 34 min

Customer Reviews

4.7 out of 5
11 Ratings

11 Ratings

laimo1bk ,

Insights into the mid Atlantic BioHealth sector

A great insiders view of biotech players in the DC region.

E Perez-Chanona ,

Great podcast about BioHealth Capital Region

Excellent resource for anyone looking to learn about the leaders, challenges and missions of the members of the BioHealth Capital Region; the biotech, academic and government research community, as well as the pharmaceutical and manufacturing industry of the D.C. metropolitan area.

Top Podcasts In Business

Prof G Markets
Vox Media Podcast Network
Money Rehab with Nicole Lapin
Money News Network
REAL AF with Andy Frisella
Andy Frisella #100to0
The Ramsey Show
Ramsey Network
Habits and Hustle
Jen Cohen and Habit Nest
The Money Mondays
Dan Fleyshman

You Might Also Like